Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Blair James C
Relationship:   10% Owner
City:   Princeton
State:   NJ
   
Insider Summary:
  
   
Companies Owned :   24    
Direct Shares   127,185    

Indirect Shares

   2,985,991      
Direct Value   $138,020    

Indirect Value

   $9,984,028      
Total Shares   3,113,176      
Total Value   $10,122,048      


Nuvasive Inc $137,416 Volcano Corp $0 Orexigen Therapeutics, Inc. $103 Clovis Oncology, Inc. $502 Nuvasive Inc $137,416 Volcano Corp $0 Orexigen Therapeutics, Inc. $103 Clovis Oncology, Inc. $502
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Welltek Incorporated WTKND Director 2008-03-07 0 2008-03-07 0    Premium*  
            Nuvasive Inc NUVA Director 2007-05-09 3,457 2007-05-09 0    Premium*  
            Senomyx Inc SNMX 10% Owner 0 2004-06-25 19,603    Premium*  
            Santarus Inc SNTS 10% Owner 2004-04-06 0 2004-04-06 64,471    Premium*  
            Somaxon Pharmaceuticals, Inc. SOMX 10% Owner 0 2006-12-21 19,379    Premium*  
            Vanda Pharmaceuticals Inc. VNDA 10% Owner 2006-04-18 0 2006-12-12 21,068    Premium*  
            Northstar Neuroscience Inc NSTR 10% Owner 0 2006-05-10 37,586    Premium*  
            Paratek Pharmaceuticals Inc PRTK 10% Owner 2006-05-15 0 2009-01-30 67,875    Premium*  
            Volcano Corp VOLC 10% Owner 2008-04-24 70,916 2008-07-16 62,513    Premium*  
            Cadence Pharmaceuticals Inc CADX Director, 10% Owner 0 2014-03-19 0    Premium*  
            Orexigen Therapeutics, Inc. OREX 10% Owner 2007-11-27 19,373 2011-12-22 50,643    Premium*  
            Alimera Sciences Inc ALIM 10% Owner 2010-04-27 0 2011-06-02 40,790    Premium*  
            Achillion Pharmaceuticals Inc ACHN 10% Owner 0 2013-01-18 244,057    Premium*  
            Zogenix, Inc. ZGNX Director, 10% Owner 2010-11-29 0 2011-09-16 169,251    Premium*  
            Clovis Oncology, Inc. CLVS Director 2019-08-16 33,439 2019-08-20 30,105    Premium*  
            Durata Therapeutics, Inc. DRTX 10% Owner 0 2012-07-24 22,306    Premium*  
            Esperion Therapeutics, Inc. ESPR 10% Owner 0 2013-07-01 35,253    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2013-07-15 0 2013-07-15 1,920,730    Premium*  
            Tobira Therapeutics Inc TBRA 10% Owner 0 2013-08-27 32,091    Premium*  
            Evoke Pharma Inc EVOK 10% Owner 0 2013-09-30 24,256    Premium*  
            Veracyte, Inc. VCYT 10% Owner 2013-11-04 0 2013-11-04 22,730    Premium*  
            Tandem Diabetes Care Inc TNDM 10% Owner 2013-11-19 0 2013-11-19 54,390    Premium*  
            Dicerna Pharmaceuticals Inc DRNA 10% Owner 2014-02-04 0 2014-02-04 13,004    Premium*  
            Achaogen Inc AKAO 10% Owner 2014-03-17 0 2014-03-17 33,890    Premium*  
* Premium Members only  

Records found :    183         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 5 of 8
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
CLVS Clovis Oncology, Inc. Director   –       •      –    2017-08-16 4 D $0.00 $0 I/I (92,518) 0 0 -
CLVS Clovis Oncology, Inc. Director   –       •      –    2017-08-16 4 A $0.00 $0 I/I 6,477 9,404 0 -
CLVS Clovis Oncology, Inc. Director   –       •      –    2018-05-21 4 A $0.00 $0 D/D 5,897 12,917 0 -
CLVS Clovis Oncology, Inc. Director   –       •      –    2018-05-21 4 D $0.00 $0 I/I (32,760) 0 0 -
CLVS Clovis Oncology, Inc. Director   –       •      –    2019-02-01 4 A $0.00 $0 I/I 10,000 10,000 0 -
CLVS Clovis Oncology, Inc. Director   –       •      –    2019-02-01 4 D $0.00 $0 I/I (1,000,000) 0 0 -
CLVS Clovis Oncology, Inc. Director   –       •      –    2019-03-18 4 A $0.00 $0 D/D 522 13,439 0 -
CLVS Clovis Oncology, Inc. Director   –       •      –    2019-03-18 4 D $0.00 $0 I/I (10,000) 0 0 -
CLVS Clovis Oncology, Inc. Director   –       •      –    2019-03-18 4 A $0.00 $0 I/I 701 10,105 0 -
NUVA Nuvasive Inc Director   –       •       •   2004-05-18 4 OE $0.63 $83,636 I/I 133,818 1,751,616 -
PRTK Paratek Pharmaceuticals I... 10% Owner   –       –       •   2009-01-29 4 S $0.91 $57,330 I/I (63,000) 71,302 0 -
PRTK Paratek Pharmaceuticals I... 10% Owner   –       –       •   2009-01-28 4 S $0.93 $34,131 I/I (36,700) 72,738 0 -
PRTK Paratek Pharmaceuticals I... 10% Owner   –       –       •   2009-01-30 4 S $0.98 $147,294 I/I (150,300) 67,875 0 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2011-12-22 4 B $1.45 $680,263 I/I 469,147 50,643 1.5 -
ZGNX Zogenix, Inc. Director   –       •       •   2011-09-16 4 B $2.00 $7,000,000 I/I 3,500,000 169,251 2.25 -
ZGNX Zogenix, Inc. Director   –       •       •   2010-11-29 4 B $4.00 $9,399,996 I/I 2,349,999 110,555 2.25 -
TBRA Tobira Therapeutics Inc 10% Owner   –       –       •   2013-08-27 4 B $4.00 $3,000,000 I/I 750,000 2,571,117 1.5 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2008-12-08 4 B $4.47 $1,110,397 I/I 248,411 4,173 1.5 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2008-12-09 4 B $4.93 $1,192,518 I/I 241,890 8,237 1.5 -
CADX Cadence Pharmaceuticals I... Director   –       •       •   2008-02-20 4 A $5.34 $14,999,996 I/I 2,808,988 90,369 0 -
CLVS Clovis Oncology, Inc. Director   –       •      –    2019-08-16 4 B $5.70 $114,000 D/D 20,000 33,439 2.39 -
CLVS Clovis Oncology, Inc. Director   –       •      –    2019-08-20 4 B $5.97 $119,400 I/I 20,000 20,000 2.1 -
OCRX Ocera Therapeutics Inc 10% Owner   –       –       •   2013-07-15 4 B $6.03 $7,999,992 I/I 1,327,491 1,897,336 1.5 -
OCRX Ocera Therapeutics Inc 10% Owner   –       –       •   2013-07-15 4/A B $6.03 $7,999,992 I/I 1,327,491 1,857,036 1.5 -
PRTK Paratek Pharmaceuticals I... Director   –       •       •   2006-05-15 4 B $6.50 $2,999,997 I/I 461,538 98,075 2.25 -
  183  Records found
  1   2   3   4   5  6   7   8      
  Page 5 of 8  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us